Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 8 (3) , 267-276
- https://doi.org/10.1016/0730-725x(90)90099-n
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- MRI Measurement of Hepatocyte Toxicity Using the New MRI Contrast Agent Manganese Dipyridoxal Diphosphate, a Manganese/Pyridoxal 5‐Phosphate ChelateMagnetic Resonance in Medicine, 1989
- Rapid 19F magnetic resonance imaging of perfluorooctyl bromide in vivoMagnetic Resonance Imaging, 1988
- Hepatic micrometastases in the rat: ferrite-enhanced MR imaging.Radiology, 1988
- 19F magnetic resonance imaging of the reticuloendothelial systemMagnetic Resonance in Medicine, 1987
- Hepatic metastases: randomized, controlled comparison of detection with MR imaging and CT.Radiology, 1987
- Evaluation of focal hepatic masses: a comparative study of MRI and CTGastrointestinal Radiology, 1986
- Pulse sequence optimization for MR imaging using a paramagnetic hepatobiliary contrast agent.Radiology, 1985
- Iron-EHPG as an Hepatobiliary MR Contrast AgentJournal of Computer Assisted Tomography, 1985
- Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complexAmerican Journal of Roentgenology, 1984
- Liver metastasesCurrent Problems in Surgery, 1981